| E | F | G | H | I | J | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | AI | AJ | AK | AL | AM | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Clinical case ID (CIDp) | Primary diagnosis | Year of collection (YYYY) | Material type | Collection media | Sample collection method | Preservation/ Fixation | Biospecimen type | Processing type | Volume (Value/ Not applied) | Measurement units | Barcode (scanned) | T Stage | N Stage | M Stage | TNM Stage | Metastasis localization | Grade (G) | Histological type | % tumor | % necrosis | Tissue type | Tumor type | Patient Age | Patient Gender | Patient Race | Disease status | Therapy history | AM/PM | PM time | Mutation Status | Gene(s) affected | Mutation Type(s) | Country of origin | |
2 | CIDp000708 | Bladder Cancer | 2017 | Tissue | LN | Resection | FF | Tissue | Fragment | 3 | item | - | 3 | 0 | 0 | III | Not applied | - | - | - | - | - | - | 69 | F | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
3 | CIDp000708 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 78849 | 3 | 0 | 0 | III | Not applied | 1 | in adipose tissue urothelial cancer growth | 5 | 0 | Tumor tissue | Primary | 69 | F | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
4 | CIDp000801 | Bladder Cancer | 2018 | Tissue | LN | Resection | FF | Tissue | Fragment | 3 | item | - | x | x | x | IIIA | unknown | - | - | - | - | - | - | 57 | M | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
5 | CIDp001273 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 88087 | 1 | 0 | 0 | I | Not applied | 3-4 | urothelial cancer of the bladder | 70 | 0-5 | Tumor tissue | Primary | 66 | M | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
6 | CIDp330000029 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000024 | 3 | 2 | 0 | III | lymph nodes | 2 | transitional cell carcinoma of the bladder | 15 | 40 | Tumor tissue | Primary | 57 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
7 | CIDp330000031 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000113 | 2 | 0 | 0 | II | Not applied | 3 | infiltrative urothelial carcinoma | 70-80 | 10 | Tumor tissue | Primary | 67 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
8 | CIDp330000033 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000127 | 2 | 0 | 0 | II | Not applied | 2 | infiltrative urothelial carcinoma | 60-70 | 0 | Tumor tissue | Primary | 58 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
9 | CIDp330000035 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000129 | 2 | 0 | 0 | II | Not applied | 2 | papillary urothelial carcinoma | 60-70 | 5 | Tumor tissue | Primary | 54 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
10 | CIDp330000037 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000135 | 2 | 0 | 0 | II | Not applied | 1 | transitional cell carcinoma of the bladder | 85 | 0 | Tumor tissue | Primary | 74 | F | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
11 | CIDp330000039 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000002 | 4 | 0 | 0 | III | Not applied | 2 | transitional cell carcinoma of the bladder | 20 | 0 | Tumor tissue | Primary | 50 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
12 | CIDp330000040 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000137 | 2 | 0 | 0 | II | Not applied | 3 | infiltrative urothelial carcinoma | 90-95 | 5-10 | Tumor tissue | Primary | 67 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
13 | CIDp330000041 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000133 | 2 | 0 | 0 | II | Not applied | 2 | infiltrative urothelial carcinoma | 60-70 | 0 | Tumor tissue | Primary | 52 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
14 | CIDp330000042 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000034 | 4 | 0 | 0 | III | Not applied | 3 | infiltrative urothelial carcinoma | 85-90 | 0 | Tumor tissue | Primary | 56 | F | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
15 | CIDp330000045 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000022 | 2 | 0 | 0 | II | Not applied | 3 | fragments of fibro-muscular tissue to the growth of urothelial carcinoma high grade | 80-85 | 5 | Tumor tissue | Primary | 67 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
16 | CIDp330000048 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000105 | 2 | 0 | 0 | II | Not applied | 2 | infiltrative urothelial carcinoma | 80-85 | 5-10 | Tumor tissue | Primary | 59 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
17 | CIDp330000050 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000109 | 2 | 0 | 0 | II | Not applied | 3 | infiltrative urothelial carcinoma | 10-15 | 5 | Tumor tissue | Primary | 66 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
18 | CIDp330000051 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000004 | 2 | 0 | 0 | II | Not applied | 2 | infiltrative urothelial carcinoma | 80-85 | 0 | Tumor tissue | Primary | 62 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
19 | CIDp330000052 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000030 | 3 | 0 | 0 | III | Not applied | 2 | infiltrative urothelial carcinoma | 90-95 | 0 | Tumor tissue | Primary | 71 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
20 | CIDp330000053 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000020 | 4 | 0 | 0 | III | Not applied | 1-2 | transitional cell carcinoma of the bladder | 10 | 0 | Tumor tissue | Primary | 68 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
21 | CIDp330000054 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000125 | 2 | 0 | 0 | II | Not applied | 2-3 | transitional cell carcinoma of the bladder | 75 | 1 | Tumor tissue | Primary | 71 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
22 | CIDp330000056 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020538 | 3 | 1 | 0 | III | lymph nodes | 2 | invasive transitional cell carcinoma of the bladder | 60 | 3 | Tumor tissue | Primary | 71 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
23 | CIDp330000061 | Bladder Cancer | 2015 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000139 | 2 | 0 | 0 | II | Not applied | 2 | transitional cell carcinoma of the bladder | 75 | 2 | Tumor tissue | Primary | 68 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
24 | CIDp330000063 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000047 | 3 | 2 | 0 | III | lymph nodes | 2 | infiltrative urothelial carcinoma | 80-85 | 0 | Tumor tissue | Primary | 60 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
25 | CIDp330000064 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000049 | 2 | 0 | 0 | II | Not applied | 1-2 | transitional cell carcinoma of the bladder | 1 | 0 | Tumor tissue | Primary | 68 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
26 | CIDp330000066 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000012 | 2 | 0 | 0 | II | Not applied | 2 | transitional cell carcinoma of the bladder | 95 | 1 | Tumor tissue | Primary | 61 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
27 | CIDp330000067 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000053 | 4 | 0 | 0 | III | Not applied | 2 | papillary urothelial carcinoma | 80-85 | 5 | Tumor tissue | Primary | 74 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
28 | CIDp330000068 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000008 | 2 | 0 | 0 | II | Not applied | 2 | infiltrative urothelial carcinoma | 15-20 | 0 | Tumor tissue | Primary | 62 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
29 | CIDp330000070 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000051 | 4 | 0 | 0 | III | Not applied | 3 | squamous cell carcinoma | 80-85 | 5-10 | Tumor tissue | Primary | 67 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
30 | CIDp330000072 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000036 | 4 | 0 | 0 | III | Not applied | 3 | infiltrative urothelial carcinoma | 50-60 | 0 | Tumor tissue | Primary | 50 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
31 | CIDp330000073 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000006 | 2 | 0 | 0 | II | Not applied | 3 | infiltrative urothelial carcinoma | 80-85 | 0 | Tumor tissue | Primary | 59 | М | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
32 | CIDp330000074 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 330000028 | 3 | 1 | 0 | III | lymph nodes | 3 | infiltrative urothelial carcinoma | 15-02 | 10 | Tumor tissue | Primary | 72 | F | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
33 | CIDp350000223 | Bladder Cancer | 2019 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780060121 | 2 | 0 | 0 | II | Not applied | 3 | urothelial carcinoma of the bladder | 85 | 3 | Tumor tissue | Primary | 62 | M | Caucasian | Primary | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
34 | CIDp350000225 | Bladder Cancer | 2019 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780060123 | 4 | 0 | x | III-IV | unknown | 2-3 | urothelial carcinoma of the bladder | 45 | 3 | Tumor tissue | Primary | 64 | M | Caucasian | Primary | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
35 | CIDp350000227 | Bladder Cancer | 2019 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780060132 | 2 | 0 | 0 | II | Not applied | 2 | urothelial carcinoma of the ureter | 95 | 0 | Tumor tissue | Primary | 78 | M | Caucasian | Primary | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
36 | CIDp350001332 | Bladder Cancer | 2019 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780170813 | 2 | 0 | 0 | II | unknown | 3 | neuroendocrine bladder cancer | 75-90 | 0-3 | Tumor tissue | Primary | 61 | M | White | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
37 | CIDp400000098 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 400000776 | 1 | 0 | 0 | I | Not applied | 2-3 | urothelial carcinoma | 90 | 0 | Tumor tissue | Primary | 53 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
38 | CIDp430000568 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 430001946 | 3b | 3 | 0 | IV | lymph nodes | 3 | fragments of muscle tissue with the growth of undifferentiated cancer | 30-40 | 10-15 | Tumor tissue | Primary | 52 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
39 | CIDP500000124 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 500000035 | 3 | 0 | 0 | III | Not applied | 2 | transitional cell bladder cancer | 75 | 3 | Tumor tissue | Primary | 69 | F | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
40 | CIDP500000131 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 500000042 | 1 | 0 | 0 | I | Not applied | 2 | transitional cell bladder cancer | 10 | 0 | Tumor tissue | Primary | 79 | F | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
41 | CIDP500000160 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 500000107 | 3 | 0 | 0 | III | Not applied | 3 | invasive transitional cell carcinoma of the bladder | 70 | 8 | Tumor tissue | Primary | 61 | М | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
42 | CIDP500000165 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 500000112 | 3 | 0 | 0 | III | Not applied | 1 | invasive transitional cell carcinoma of the bladder | 25 | 0 | Tumor tissue | Primary | 64 | М | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
43 | CIDP500000171 | Bladder Cancer | 2016 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 500000118 | 3 | 0 | 0 | III | Not applied | - | bladder wall | 0 | 0 | Normal tissue | Primary | 75 | М | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
44 | CIDP500000239 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 500000142 | 3 | 0 | 0 | III | Not applied | 2 | infiltrative urothelial carcinoma | 75-80 | 5 | Tumor tissue | Primary | 67 | М | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
45 | CIDP500000265 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 500000167 | 2 | 0 | 0 | II | Not applied | 2 | transitional cell carcinoma of the bladder | 75 | 0 | Tumor tissue | Primary | 23 | М | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
46 | CIDP500000283 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 500000185 | 2 | 0 | 0 | II | Not applied | 2-3 | transitional cell carcinoma of the bladder | 25 | 0 | Tumor tissue | Primary | 61 | М | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
47 | CIDP500000284 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 500000186 | 3 | 0 | 0 | III | Not applied | 2-3 | transitional cell carcinoma of the bladder | 70 | 1 | Tumor tissue | Primary | 58 | F | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
48 | CIDp500000605 | Bladder Cancer | 2020 | Blood | Cell Free DNA Streck | Venopunction | Frozen | Plasma | Double spun | 39 | ml | - | 2b | 0 | 0 | II | Not applied | - | - | - | - | - | - | 80 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
49 | CIDp500027 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 75117 | 1 | 0 | 0 | I | Not applied | 4 | urothelial carcinoma | 95 | 5 | Tumor tissue | Primary | 61 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
50 | CIDp530000054 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020177 | 3 | 0 | 0 | IIIA | Not applied | 2 | infiltrative urothelial carcinoma | 40-70 | 10-30 | Tumor tissue | Primary | 72 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
51 | CIDp530000055 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020178 | 3 | 0 | 0 | IIIA | Not applied | 1 | papillary urothelial carcinoma | 95-98 | 0 | Tumor tissue | Primary | 60 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
52 | CIDp530000056 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020179 | 3 | 0 | 0 | IIIA | Not applied | 1 | papillary urothelial carcinoma | 40-100 | 0 | Tumor tissue | Primary | 67 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
53 | CIDp530000057 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020180 | 3 | 0 | 0 | IIIA | Not applied | 2 | infiltrative urothelial carcinoma | 85-90 | 0 | Tumor tissue | Primary | 73 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
54 | CIDp530000058 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020181 | 3 | 0 | 0 | IIIA | Not applied | 2 | papillary urothelial carcinoma | 80 | 10 | Tumor tissue | Primary | 59 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
55 | CIDp530000059 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020182 | 3 | 0 | 0 | IIIA | Not applied | 1 | papillary urothelial carcinoma | 85-95 | 0 | Tumor tissue | Primary | 80 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
56 | CIDp530000060 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020183 | 3 | 0 | 0 | IIIA | Not applied | 3 | infiltrative urothelial carcinoma | 40-90 | 5 | Tumor tissue | Primary | 66 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
57 | CIDp530000061 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020184 | 3 | 0 | 0 | IIIA | Not applied | 3 | infiltrative urothelial carcinoma | 85-90 | 5 | Tumor tissue | Primary | 68 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
58 | CIDp530000062 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020185 | 3 | 0 | 0 | IIIA | Not applied | 3 | infiltrative urothelial carcinoma | 80-90 | 30-40 | Tumor tissue | Primary | 46 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
59 | CIDp530000063 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020186 | 3 | 0 | 0 | IIIA | Not applied | 3 | infiltrative urothelial carcinoma | 80-90 | 20-30 | Tumor tissue | Primary | 77 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
60 | CIDp530000064 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020187 | 3 | 0 | 0 | IIIA | Not applied | 2 | papillary urothelial carcinoma | 90-95 | 5 | Tumor tissue | Primary | 72 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
61 | CIDp530000065 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020188 | 3 | 0 | 0 | IIIA | Not applied | 3 | infiltrative urothelial carcinoma | 40-90 | 0 | Tumor tissue | Primary | 67 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
62 | CIDp530000131 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020189 | 3 | 0 | 0 | IIIA | Not applied | 1 | papillary urothelial carcinoma | 60-70 | 0 | Tumor tissue | Primary | 55 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
63 | CIDp530000132 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020190 | 3 | 0 | 0 | IIIA | Not applied | 2 | infiltrative urothelial carcinoma | 60-95 | 0 | Tumor tissue | Primary | 79 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
64 | CIDp530000133 | Bladder Cancer | 2018 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780020191 | 3 | 0 | 0 | IIIA | Not applied | 2 | papillary urothelial carcinoma | 90-95 | 5-10 | Tumor tissue | Primary | 82 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
65 | CIDp560000305 | Bladder Cancer | 2020 | Blood | Cell Free DNA Streck | Venopunction | Frozen | Plasma | Double spun | 20 | ml | - | 1 | 0 | 0 | I | Not applied | - | urothelial cancer | - | - | - | - | 66 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
66 | CIDp560000306 | Bladder Cancer | 2020 | Blood | Cell Free DNA Streck | Venopunction | Frozen | Plasma | Double spun | 13 | ml | - | 1 | 0 | 0 | I | Not applied | - | urothelial cancer | - | - | - | - | 53 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
67 | CIDp560000306 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 630008300 | 1 | 0 | 0 | I | Not applied | 2 | transitional cell carcinoma of the bladder | 5-7 | 0 | Tumor tissue | Primary | 53 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
68 | CIDp560000306 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 630008302 | 1 | 0 | 0 | I | Not applied | - | chronic cystitis | 0 | 0 | Other | Not applied | 53 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
69 | CIDp560000308 | Bladder Cancer | 2020 | Blood | Cell Free DNA Streck | Venopunction | Frozen | Plasma | Double spun | 18.9 | ml | - | 1 | 0 | 0 | I | Not applied | - | urothelial cancer | - | - | - | - | 72 | F | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
70 | CIDp560000308 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 630008304 | 1 | 0 | 0 | I | Not applied | 2 | transitional cell carcinoma of the bladder | 3-4 | 0 | Tumor tissue | Primary | 72 | F | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
71 | CIDp560000308 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 630008306 | 1 | 0 | 0 | I | Not applied | - | chronic cystitis | 0 | 0 | Other | Not applied | 72 | F | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
72 | CIDp560000315 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 630008875 | 2 | 0 | 0 | II | Not applied | 2 | papillary urothelial carcinoma | 85-90 | 0 | Tumor tissue | Primary | 46 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
73 | CIDp560000316 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 630008881 | 1 | 0 | 0 | I | Not applied | 2 | papillary urothelial carcinoma | 90 | 0 | Tumor tissue | Primary | 71 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
74 | CIDp560000317 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 630008889 | 1 | 0 | 0 | I | Not applied | 2 | papillary urothelial carcinoma | 80-85 | 0 | Tumor tissue | Primary | 71 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
75 | CIDp560000325 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 630008935 | 1 | 0 | 0 | I | Not applied | 2 | urothelial carcinoma, high grade | 85-90 | 5 | Tumor tissue | Primary | 37 | M | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
76 | CIDp560000326 | Bladder Cancer | 2017 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 520012982 | 1 | 0 | 0 | I | Not applied | - | fragment of the bladder wall without tumor elements | 0 | 0 | Normal tissue | Primary | 61 | М | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
77 | CIDp560000329 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 520012973 | 1 | 0 | 0 | I | Not applied | 2 | invasive urothelial carcinoma | 70 | 3-5 | Tumor tissue | Primary | 62 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
78 | CIDp560000330 | Bladder Cancer | 2020 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 520012978 | 1 | 0 | 0 | I | Not applied | 1 | urothelial carcinoma | 50 | 0 | Tumor tissue | Primary | 55 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
79 | CIDp610000835 | Bladder Cancer | 2020 | Blood | Cell Free DNA Streck | Venopunction | Frozen | Plasma | Double spun | 20 | ml | - | 1 | 0 | 0 | I | Not applied | - | papillary urothelial carcinoma G2 with growth into subepithelial connective tissue | - | - | - | - | 65 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
80 | CIDp610000899 | Bladder Cancer | 2020 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 4 | ml | - | 2b | 1 | 0 | IV | lymph nodes | - | - | - | - | - | - | 70 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
81 | CIDp610000899 | Bladder Cancer | 2020 | Blood | SST | Venopunction | Frozen | Serum | Standard spun | 3 | ml | - | 2b | 1 | 0 | IV | lymph nodes | - | - | - | - | - | - | 70 | M | Caucasian | Primary | Untreated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
82 | CIDp620000094 | Bladder Cancer | 2019 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 13 | ml | - | x | x | x | I-IV | unknown | - | - | - | - | - | - | 64 | M | Caucasian | Unknown | Unknown | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
83 | CIDp620000097 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001347 | 3 | x | x | III-IV | unknown | 3 | urothelial carcinoma | 66 | 3-6 | Tumor tissue | Primary | 56 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
84 | CIDp620000098 | Bladder Cancer | 2011 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001360 | 3-4 | x | x | III-IV | unknown | 2 | urothelial carcinoma | 98 | 0 | Tumor tissue | Primary | 44 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
85 | CIDp620000098 | Bladder Cancer | 2011 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780065237 | 3-4 | x | x | III-IV | unknown | 2 | urothelial carcinoma | 100 | 0 | Tumor tissue | Primary | 44 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
86 | CIDp620000098 | Bladder Cancer | 2011 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 780065238 | 3-4 | x | x | III-IV | unknown | 2 | urothelial carcinoma | 100 | 0 | Tumor tissue | Primary | 44 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
87 | CIDp620000099 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001348 | 3 | 0 | 0 | III | Not applied | 3 | papillary urothelial carcinoma | 70-80 | 5 | Tumor tissue | Primary | 80 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
88 | CIDp620000100 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001349 | 1 | 0 | 0 | I | Not applied | 0 | muscle tissue | 0 | 0 | Normal tissue | Primary | 76 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
89 | CIDp620000100 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001354 | 1 | 0 | 0 | I | Not applied | 3 | muscle + very small focus of urothelial carcinoma | 1 | 0 | Tumor tissue | Primary | 76 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
90 | CIDp620000101 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001350 | 1 | 0 | 0 | I | Not applied | 2 | urothelial carcinoma | 100 | 0 | Tumor tissue | Primary | 76 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
91 | CIDp620000101 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001351 | 1 | 0 | 0 | I | Not applied | 2 | urothelial carcinoma | 3-4 | 0 | Tumor tissue | Primary | 76 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
92 | CIDp620000101 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001352 | 1 | 0 | 0 | I | Not applied | 2 | urothelial carcinoma | 100 | 0 | Tumor tissue | Primary | 76 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
93 | CIDp620000101 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001353 | 1 | 0 | 0 | I | Not applied | 3 | urothelial carcinoma | 100 | 0 | Tumor tissue | Primary | 76 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
94 | CIDp620000102 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001357 | 2-3 | x | 0 | II-IV | Not applied | 2 | urothelial carcinoma | 100 | 0 | Tumor tissue | Primary | 74 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
95 | CIDp620000102 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001358 | 2-3 | x | 0 | II-IV | Not applied | 2 | urothelial carcinoma | 93 | 0 | Tumor tissue | Primary | 74 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
96 | CIDp620000102 | Bladder Cancer | 2012 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001359 | 2-3 | x | 0 | II-IV | Not applied | 2 | urothelial carcinoma | 75 | 0 | Tumor tissue | Primary | 74 | M | Caucasian | Primary | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
97 | CIDp620000131 | Bladder Cancer | 2019 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 4 | ml | - | 4 | 3 | 0 | IV | lymph nodes | - | - | - | - | - | - | 67 | M | Caucasian | Relapsed | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
98 | CIDp620000131 | Bladder Cancer | 2019 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001303 | 4 | 3 | 0 | IV | lymph nodes | 2 | urothelial carcinoma of the bladder | 15-20 | 0 | Tumor tissue | Primary | 67 | M | Caucasian | Relapsed | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
99 | CIDp620000131 | Bladder Cancer | 2019 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001308 | 4 | 3 | 0 | IV | lymph nodes | 2 | urothelial carcinoma of the bladder | 1 | 0 | Tumor tissue | Primary | 67 | M | Caucasian | Relapsed | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation | |
100 | CIDp620000131 | Bladder Cancer | 2019 | Tissue | NBF 10% | Resection | FFPE | Tissue | Block | 1 | item | 620001309 | 4 | 3 | 0 | IV | lymph nodes | 2 | urothelial carcinoma of the bladder | 30 | 0 | Tumor tissue | Primary | 67 | M | Caucasian | Relapsed | Treated | Ante-mortem | Not applied | Unknown | Not applied | Not applied | Russian Federation |